Fierce Biotech December 22, 2023
Conor Hale

If Fierce Medtech’s most-read stories of 2022 illustrated the industry’s return to some semblance of post-COVID normalcy, then 2023’s picks showed how many are realigning themselves to meet the harsh new realities that came with it.

Layoffs, spinoffs, bankruptcies—and, in one case, jail time—together set the themes for our top 10 list.

Our most-read story focused on a stepping stone in Elizabeth Holmes’ journey to federal prison this year after she was convicted of committing fraud during her time as Theranos’ CEO. A quick court hearing in March ended up delaying a final ruling on when Holmes would have to begin serving her sentence of more than 11 years—as well as how much money she would have to pay back...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article